Trial Details
COMPLETEDBasic Information
| Clinical ID | c1680 |
|---|---|
| Identifier | NCT00729872 |
| Trial Title | A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderately Active Ulcerative Colitis |
| Interventions | BIOLOGICAL: AG011|OTHER: Placebo |
Participant Information
| Sponsor | ActoGeniX N.V. |
|---|---|
| City | Bonheiden |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-07-08 |
|---|---|
| Primary Completion Date | 2025-09-09 |
| Completion Date | 2025-09-09 |